Magnetic Resonance Imaging Contrast Agents Market

MRI contrast agents are paramagnetic substances, such as metal ions such as iron, thorium, manganese, etc., whose atoms have several unpaired electrons, have a long relaxation time, have a large magnetic moment, and are oriented in a uniform magnetic field Consistent with the direction of the magnetic field, it is equivalent to increasing the effect of the static field strength, so that when the excited protons or energy is transferred from the protons to the surrounding environment, the relaxation time is shortened. Simply put, it is a potion used to identify benign and malignant objects on the body.

Magnetic Resonance Imaging Contrast Agents Market contains market size and forecasts of Magnetic Resonance Imaging (MRI) Contrast Agents in global, including the following market information:

• Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Magnetic Resonance Imaging (MRI) Contrast Agents companies in 2021 (%)

The global Magnetic Resonance Imaging (MRI) Contrast Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Paramagnetic Contrast Agent Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Magnetic Resonance Imaging (MRI) Contrast Agents include Bayer, GE Healthcare, Guerbet, Bracco Imaging and Miltenyi Biotec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Magnetic Resonance Imaging (MRI) Contrast Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Segment Percentages, by Type, 2021 (%)

• Paramagnetic Contrast Agent
• Superparamagnetic Contrast Agents

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnetic Resonance Imaging (MRI) Contrast Agents Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Magnetic Resonance Imaging (MRI) Contrast Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Magnetic Resonance Imaging (MRI) Contrast Agents revenues share in global market, 2021 (%)
• Key companies Magnetic Resonance Imaging (MRI) Contrast Agents sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Magnetic Resonance Imaging (MRI) Contrast Agents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• GE Healthcare
• Guerbet
• Bracco Imaging
• Miltenyi Biotec